PEAK6 Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

PEAK6 Group’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$764K	Sell	29,900 -1,000	-3%	-$23.3K	﹤0.01%	2209
2018 Q1	$623K	Sell	30,900 -15,500	-33%	-$362K	﹤0.01%	2377
2017 Q4	$931K	Buy	+46,400	New	+$912K	﹤0.01%	1978
2016 Q4	–	Sell	-800	Closed	-$22K	–	5278
2016 Q3	$22K	Buy	+800	New	+$26.8K	﹤0.01%	4083
2015 Q4	–	Sell	-13,300	Closed	-$382K	–	5568
2015 Q3	$382K	Buy	+13,300	New	+$569K	﹤0.01%	3147
2015 Q2	–	Sell	-10,000	Closed	-$346K	–	5676
2015 Q1	$346K	Buy	+10,000	New	+$272K	﹤0.01%	2931

Other funds holding DPLO

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PEAK6 Group's DPLO Position: Q2 2018 in Review

PEAK6 Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 17,212 shares — an estimated $401K sold.

PEAK6 Group first reported a position in DPLO in Q3 2015 and held it in 4 quarters. The position peaked at $680K in Q3 2017. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

PEAK6 Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
PEAK6 Group sold 17,212 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $401K.
PEAK6 Group first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2015 and held it in 4 quarters.
PEAK6 Group's DIPLOMAT PHARMACY, INC. position peaked at $680K in Q3 2017.
206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.